Asif Masood is a Regulatory professional with 20+ years of global biotech experience with companies such as J&J, Gilead Sciences, Roche and BioMarin etc. Asif’s has supported product development for both small and large molecules including combination products and ATMPs spanning across wide diverse therapeutic areas such as CNS, oncology, infectious diseases, cardio-renal and orphan indications from early development to late-stage development investigative studies and marketing applications. He’s been a Global Regulatory Lead for several Blockbuster products such as Concerta, Xtandi, Kadcyla, Kuvan amongst others. Asif has been the sole regulatory expert for stem cell therapies for Ischemic stroke and traumatic brain injury in Phase 3 registration study and marketing application aspirations.